You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

8-oxo-7,8-dihydro-2'-deoxyguanosine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial in Hellerup (Empagliflozin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Hellerup, Denmark
    Center for Diabetes Research, Gentofte Hospital
Jun 9, 2021

Non Small Cell Lung Cancer, NSCLC, Stage III, Nsclc Trial in Stanford (Durvalumab, Carboplatin, Pemetrexed)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Stanford, California
    Stanford University
Oct 27, 2022

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Follicular Lymphoma, Recurrent Indolent Adult Non-Hodgkin Lymphoma Trial in

Suspended
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 20, 2023

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Columbus

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 28, 2022

Breast Cancer, Breast Carcinoma, Metastatic Breast Cancer Trial in New York (18F-FDG PET/CT, [18F]-Fluoro-2-Deoxy-D-Glucose and

Recruiting
  • Breast Cancer
  • +4 more
  • 18F-FDG PET/CT
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 17, 2023

Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage IV Major Salivary Gland Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Salivary Gland Carcinoma
  • +5 more
  • Pembrolizumab
  • Pemetrexed Disodium
  • Scottsdale, Arizona
  • +2 more
Mar 15, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (Palbociclib, Tazemetostat,

Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Jan 13, 2023

Head and Neck Tumors Trial (TransCon TLR7/8 Agonist, Pembrolizumab, TransCon IL-2 ß/?)

Not yet recruiting
  • Head and Neck Neoplasms
  • TransCon TLR7/8 Agonist
  • +2 more
  • (no location specified)
Aug 4, 2023

Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial run by the National Cancer

Recruiting
  • Adrenal Gland Pheochromocytoma
  • +3 more
  • Computed Tomography
  • +2 more
  • Bethesda, Maryland
  • +1 more
Jan 3, 2023

Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York

Not yet recruiting
  • Locally Advanced Leiomyosarcoma
  • +8 more
  • (no location specified)
Jul 6, 2022

Extensive Stage Lung Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Recurrent Lung Small Cell Carcinoma Trial in

Recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +5 more
  • Indianapolis, Indiana
  • +2 more
Oct 26, 2022

MGMT-Methylated Glioblastoma, Recurrent Glioblastoma, IDH-Wildtype Trial (Selinexor, Temozolomide)

Not yet recruiting
  • MGMT-Methylated Glioblastoma
  • Recurrent Glioblastoma, IDH-Wildtype
  • (no location specified)
Jun 28, 2022

Malignant Supratentorial Tumor, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (Lonafarnib, Temozolomide)

Active, not recruiting
  • Malignant Supratentorial Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2021

Glioblastoma, Gliosarcoma Trial in Houston (drug, radiation, procedure)

Recruiting
  • Glioblastoma
  • Gliosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2022

Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

Recruiting
  • Anaplastic Astrocytoma, IDH-Wildtype
  • +8 more
  • Quality-of-Life Assessment
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 8, 2022

Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in San Francisco (drug,

Withdrawn
  • Lung Non-Small Cell Carcinoma
  • +9 more
  • San Francisco, California
    University of California, San Francisco
Feb 17, 2022

Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy,

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Jan 18, 2023

Astrocytoma, Glioblastoma, Glioblastoma, IDH-Wildtype Trial in Chicago (drug, other, radiation)

Recruiting
  • Astrocytoma
  • +4 more
  • Mycophenolate Mofetil
  • +3 more
  • Chicago, Illinois
    Northwestern University
Aug 22, 2022

Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III

Terminated
  • Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • +9 more
  • Bintrafusp Alfa
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 4, 2022

Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Duarte, New Haven (Copanlisib Hydrochloride,

Recruiting
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Duarte, California
  • +1 more
Aug 3, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Suspended
  • Anatomic Stage III Breast Cancer AJCC v8
  • +12 more
  • Copanlisib Hydrochloride
  • Eribulin Mesylate
  • Gainesville, Florida
  • +10 more
Nov 16, 2022

Photoaging Trial (In a double-blinded fashion, 250 mg CANNAXR cream, Topical VEHICLE cream)

Not yet recruiting
  • Photoaging
  • In a double-blinded fashion, 250 mg CANNAXR cream
  • Topical VEHICLE cream
  • (no location specified)
Aug 23, 2022

Recurrent Extensive Stage Small Cell Lung Carcinoma, Refractory Extensive Stage Small Cell Lung Carcinoma Trial in United States

Active, not recruiting
  • Recurrent Extensive Stage Small Cell Lung Carcinoma
  • Refractory Extensive Stage Small Cell Lung Carcinoma
  • Bakersfield, California
  • +5 more
Jan 5, 2023

Bladder Carcinoma, Refractory Bladder Carcinoma, Urinary Tract Infection Trial in Buffalo (Clindamycin, Diary, Ertapenem)

Recruiting
  • Bladder Carcinoma
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 3, 2022

Smallpox, Monkeypox, Cowpox Trial in Novosibirsk (NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally,

Completed
  • Smallpox
  • +3 more
  • NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally
  • +5 more
  • Novosibirsk, Koltsovo, Novosibirsk Region, Russian Federation
    Federal State Budgetary Healthcare Institution - Medical and San
Jul 27, 2023